Nvidia is still the dominant force in artificial intelligence chips, but investors are becoming more cautious as competition grows from both traditional semiconductor rivals and
Intellia Therapeutics rose sharply after reporting successful late-stage results for its experimental gene-editing treatment for hereditary angioedema, a rare disorder that causes dangerous and recurring
Eli Lilly’s newly approved weight-loss pill has cleared an important regulatory hurdle, but the U.S. Food and Drug Administration is requiring the company to carry
Nvidia is still the dominant force in artificial intelligence chips, but investors are becoming more cautious as competition grows from both traditional semiconductor rivals and
A growing divide is emerging within the Democratic Party over how to frame the political debate around artificial intelligence, as leaders increasingly emphasize affordability while
The Lucas Museum of Narrative Art has unveiled the first exhibitions visitors will see when the long-awaited Los Angeles institution opens on Sept. 22, and
Blue Owl Capital has agreed to acquire Sila Realty Trust in an all-cash deal valued at about $2.4 billion, expanding its push into healthcare real
Nvidia is still the dominant force in artificial intelligence chips, but investors are becoming more cautious as competition grows from both traditional semiconductor rivals and
Climate scientists are increasingly warning that Earth may be heading toward one of the strongest El Niño events in modern history, a development that could
The New York Finance is the premier platform for bold innovation, visionary leadership, and next-generation entrepreneurship. Dive into compelling stories of emerging ventures, market game-changers, and influential leaders redefining the business landscape. Stay informed with exclusive rankings, strategic insights, and the key trends shaping the global financial future.
Never miss any important news. Subscribe to our newsletter.
Copyright 2026 - The New York Finance - All rights reserved.
Never miss any important news. Subscribe to our newsletter.
